PMCB Stock Analysis: Buy, Sell, or Hold?

PMCB - PharmaCyte Biotech, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
$0.72
-0.03 (-3.51%) ▼
5d: -5.77%
30d: -4.82%
90d: +3.73%
HOLD
MODERATE Confidence
Analysis Updated: Jul 2, 2026 12:00 AM ET
Earnings: Aug 14, 2026

Get Alerted When PMCB Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
📊 HOLD: PMCB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: PMCB is currently trading at $0.71, which is considered oversold relative to its 30-day fair value range of $0.72 to $0.80.

Technical Outlook: Technically, PMCB is showing sideways momentum. Immediate support is located at $0.67, while resistance sits at $0.87. Short-term momentum is weak, with the stock down 3.5% recently.

Market Sentiment: PMCB has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.

Quick Decision Summary

Current Position OVERSOLD
Historical Trading Range $0.72 - $0.80
Company Quality Score 51/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 47.1%

All Signals

  • BULLISH: Price oversold vs 30-day range
  • BEARISH: Weak technical setup (25/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.5%)
  • CAUTION: 5-day price weakness (-5.8%) - monitor closely

Trading Range Analysis

30-Day Trading Range $0.72 - $0.80
Current vs Trading Range OVERSOLD

Support & Resistance Levels

Support Level $0.67
Resistance Level $0.87
Current Trend Sideways
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) 7.02
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: July 02, 2026 10:40 PM ET
Data refreshes hourly during market hours. Next update: 11:40 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
4
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Jonathan Schechter BUY 20000 shares 2026-01-07
Joshua Silverman BUY 40000 shares 2026-01-07
Jonathan Schechter BUY 20000 shares 2026-01-05

Unlock Insider Activity

See real-time buying/selling by company executives for PMCB.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
VRTX
Vertex Pharmaceuticals I…
BUY
34 analysts
$549 59 HOLD
CYTK
Cytokinetics Inc
STRONG BUY
21 analysts
$106 64 BUY
XENE
Xenon Pharmaceuticals Inc
STRONG BUY
19 analysts
$81 54 HOLD
INCY
Incyte Corporation
HOLD
27 analysts
$110 61 BUY
MLTX
MoonLake Immunotherapeut…
STRONG BUY
16 analysts
$28 45 HOLD

More Analysis for PMCB

PMCB Technical Chart PMCB Price Prediction PMCB Earnings Date PMCB Investment Advisor PMCB Fair Price Analyzer PMCB Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals